| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.09 |